BioWorld MedTech

June 13, 2017

Myomo offers robotics industry IPO

Medical robotics company Myomo Inc. goes public with IPO offering of $5 million at $7.50 per share. The Cambridge, Mass., company specializes in mobility devices for the arms and hands. Read More

Patients see sustained metabolic improvement from Endobarrier

Gottlieb says FDA drafting guidance addressing regenerative medicine

Medtronic dives deep with new visual software for a closer view of the brain

Bonesupport goes public, aims to raise $57M

Appointments and advancements

Daily M&A

Other news to note

Product briefs

Regulatory front

BioWorld MedTech's Cardiology Extra

Today's news in brief

BioWorld

BioWorld briefs for March 19, 2026.

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

Keros reports beneficial effects of RKER-065 in ALS model

BioWorld Science

Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026

First-in-class POLG activator restores mtDNA across mutations

BioWorld Science

Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...